Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant Tetra Stent Approval Opens Opportunity To Recoup Lost Market Share

This article was originally published in The Gray Sheet

Executive Summary

Guidant is looking to its Multi-Link Tetra fourth-generation coronary stent platform to recoup a recent loss in U.S. stent market share, following a drop-off in demand for its Tri-Star stent.
Advertisement

Related Content

Guidant
Guidant
Dick Cheney
Dick Cheney
Guidant
Guidant
Guidant Prizm 2, HE AICD Launches Will Benefit From Sales Force Expansion
Guidant Prizm 2, HE AICD Launches Will Benefit From Sales Force Expansion
Advertisement
UsernamePublicRestriction

Register

MT013960

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel